Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.
about
Effect of meditation on cognitive functions in context of aging and neurodegenerative diseasesTranscendental meditation for the primary prevention of cardiovascular diseaseTranscendental meditation for the primary prevention of cardiovascular diseaseLong-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertensionCan meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeresMind-body therapies for menopausal symptoms: a systematic review.Levels of immune cells in transcendental meditation practitioners.Can yoga practices benefit health by improving organism regulation? Evidence from electrodermal measures of acupuncture meridiansSitting-meditation interventions among youth: a review of treatment efficacyInvestigating the effect of transcendental meditation on blood pressure: a systematic review and meta-analysis.Effects of the Transcendental Meditation Program on Substance Use among University Students.Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence.Meditation: Process and effects.Rapid colonoscopy preparation using bolus lukewarm saline combined with sequential posture changes: a randomized controlled trialReduced Trauma Symptoms and Perceived Stress in Male Prison Inmates through the Transcendental Meditation Program: A Randomized Controlled Trial.Effect of transcendental meditation on employee stress, depression, and burnout: a randomized controlled study.Transcendental Meditation and Reduced Trauma Symptoms in Female Inmates: A Randomized Controlled StudyEmotional stressors trigger cardiovascular events.Impact of acute psychological stress on cardiovascular risk factors in face of insulin resistance.A Buddhist-based meditation practice for care and healing: an introduction and its application.The Relationship Between Focused Attention Meditation Practice Habits, Psychological Symptoms, and Quality of Life.Buddhist religious practices and blood pressure among elderly in rural Uttaradit Province, northern Thailand.Breath of Life: The Respiratory Vagal Stimulation Model of Contemplative ActivityEffect of Meditation on Emotional Intelligence and Perceived Stress in the Workplace: A Randomized Controlled Study
P2860
Q22241232-4155FEE4-9461-4EF1-8D74-5F90F1E9ABADQ24187502-12F0B30E-E249-47B0-A03B-5061ED390E79Q24201203-218ABC6B-4971-4C83-B20E-823435FA1F65Q24548600-ADA58C7A-F151-43C8-9D02-189210C4BB90Q24599336-04F94939-CB64-4755-A36A-77C6E0D647CDQ30432169-1472C45D-0243-4E31-B8C9-FADE257470A4Q33900862-FDB304E4-BD77-408C-B9BF-5877AC099420Q33900898-04BDC6F9-A566-4FF4-BB39-4A2E33114443Q34019076-9ACDE7DE-903D-4731-8994-C0AD3E8EB9C4Q34462268-B18E2EE7-8426-40EB-A931-93F75B4B2A7AQ34929549-707CDFE0-7A3C-45DB-9315-A1C887267BD2Q35786266-C155D87F-B49A-493A-B788-8E283DE0B443Q36900153-91273F50-8D33-4A80-9A87-908C8B518663Q36975809-B68C968F-E271-414C-B831-775C3D225B7CQ37064528-1BDE95B4-6483-48F3-A4DD-AA3251A8869FQ37401955-F3C8C568-A837-4548-9B2C-727EC59867D6Q37632473-BC7305A5-FACA-4436-BA7D-FEA40AB2A259Q37718729-96FFDCF0-C9D3-48FA-B9D9-70A5D0EA89D3Q38018723-20E5A5D4-F979-4B38-A2B3-5EA2D3BA20C0Q42913697-8296D50A-2572-43E2-8E68-F5C898E7F5C0Q45852919-142A0F94-D47A-4D29-AB8D-3E54216C3CABQ47819201-D63BA7C1-7EB9-43EE-A3C3-09B2EB68E14AQ48216783-04892DDB-FD4E-4425-BA7F-1500482B66D6Q57816666-8C2D2DD9-BC32-4944-8810-812D8DA18866Q58698526-9E92A1B2-FD7C-4BC5-ABBB-DF789D5A0E99
P2860
Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Review of controlled research ...... ors, morbidity, and mortality.
@ast
Review of controlled research ...... ors, morbidity, and mortality.
@en
type
label
Review of controlled research ...... ors, morbidity, and mortality.
@ast
Review of controlled research ...... ors, morbidity, and mortality.
@en
prefLabel
Review of controlled research ...... ors, morbidity, and mortality.
@ast
Review of controlled research ...... ors, morbidity, and mortality.
@en
P2093
P2860
P1433
P1476
Review of controlled research ...... ors, morbidity, and mortality.
@en
P2093
Kenneth G Walton
Robert H Schneider
Sanford Nidich
P2860
P304
P356
10.1097/01.CRD.0000113021.96119.78
P577
2004-09-01T00:00:00Z